Human Mast Cell Apoptosis Is Regulated Through Bcl-2 and Bcl-XL

被引:0
|
作者
Yoseph A. Mekori
Alasdair M. Gilfillan
Cem Akin
Karin Hartmann
Dean D. Metcalfe
机构
[1] Tel-Aviv University,Department of Medicine Meir General Hospital, Kfar
[2] National Institutes of Health,Saba and Sackler School of Medicine
来源
关键词
Apoptosis; Bcl-2; Bcl-X; c-kit; mast cell;
D O I
暂无
中图分类号
学科分类号
摘要
It is well established that human mast cell proliferation and maturation are regulated by kit ligand (stem cell factor). Little is known, however, about how these two processes are negatively regulated and thus, how mast cell number is controlled in normal and pathologic conditions. We therefore first hypothesized that SCF-dependent human mast cells would undergo programmed cell death (apoptosis) on removal of SCF as has been shown for growth factor-dependent rodent mast cells. We then examined whether SCF acts as a survival factor through the regulation of the bcl-2 family of apoptosis-regulatory genes. As hypothesized, elimination of SCF from primary peripheral blood-derived human mast cell cultures resulted in a significant apoptotic process. During apoptosis, down-regulation of the two apoptosis-regulatory proteins Bcl-2 and Bcl-XLwas observed. Moreover, a deregulated expression of these two proteins was found in two human mast cell lines which are SCF-independent. Thus, SCF functions as a survival factor by repressing apoptosis of human mast cells through Bcl-2 and Bcl-XL. Deregulated expression of these antiapoptotic proteins may contribute to proliferation and accumulation of mast cells in certain forms of systemic mast cell disorders.
引用
收藏
页码:171 / 174
页数:3
相关论文
共 50 条
  • [31] Regulation of B cell apoptosis by Bcl-2 and Bcl-XL and its role in the development of autoimmune diseases (Review)
    Lopez-Hoyos, M
    Carrio, R
    Merino, J
    Merino, R
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 1998, 1 (02) : 475 - 483
  • [32] Bcl-2 and Bcl-XL are indispensable for the late phase of mast cell development from mouse embryonic stem cells
    Moeller, Christine
    Karlberg, Mats
    Abrink, Magnus
    Nakayama, Keiiehi I.
    Motoyama, Noboru
    Nilsson, Gunnar
    EXPERIMENTAL HEMATOLOGY, 2007, 35 (03) : 385 - 393
  • [33] RAPLINK-1 COOPERATES WITH INHIBITORS OF BCL-2/BCL-XL TO INDUCE APOPTOSIS IN GLIOBLASTOMA
    Luo, Xujun
    Fan, Qi-Wen
    Shokat, Kevan M.
    Weiss, William A.
    NEURO-ONCOLOGY, 2019, 21 : 115 - 115
  • [34] Bcl-2/Bcl-xL inhibitor navitoclax increases the antitumor effect of Chk1 inhibitor prexasertib by inducing apoptosis in pancreatic cancer cells via inhibition of Bcl-xL but not Bcl-2
    Yoshihito Morimoto
    Kimihiko Takada
    Osamu Takeuchi
    Kazuhiro Watanabe
    Masayoshi Hirohara
    Tomoyuki Hamamoto
    Yutaka Masuda
    Molecular and Cellular Biochemistry, 2020, 472 : 187 - 198
  • [35] Plant Food Anthocyanins Induced Platelet Apoptosis Via BCL-2/BCL-XL Pathway
    Yan, Yang
    Jing, Ma
    Tian Jinju
    Chen Liyi
    Yin, Songmei
    Ni, Heyu
    Ling Wenhua
    BLOOD, 2014, 124 (21)
  • [36] In-silico screening of new potential Bcl-2/Bcl-xl inhibitors as apoptosis modulators
    Anna Maria Almerico
    Marco Tutone
    Antonino Lauria
    Journal of Molecular Modeling, 2009, 15 : 349 - 355
  • [37] Resistance to apoptosis induced by Bcl-2 and or Bcl-xL favours metastatic progression of breast cancer
    Fernández, Y
    Mañas, S
    España, L
    Torregrosa, A
    Fabra, A
    Sierra, A
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S11 - S11
  • [38] In-silico screening of new potential Bcl-2/Bcl-xl inhibitors as apoptosis modulators
    Almerico, Anna Maria
    Tutone, Marco
    Lauria, Antonino
    JOURNAL OF MOLECULAR MODELING, 2009, 15 (04) : 349 - 355
  • [39] Expression Of Bcl-2, Bax and Bcl-xl in Human Gliomas: A Re-appraisal
    Stéphane Martin
    Claire Toquet
    Lisa Oliver
    Pierre-François Cartron
    Pascale Perrin
    Khaled Meflah
    Paulette Cuillère
    François M. Vallette
    Journal of Neuro-Oncology, 2001, 52 : 129 - 139
  • [40] Bcl-2/Bcl-xL inhibitor navitoclax increases the antitumor effect of Chk1 inhibitor prexasertib by inducing apoptosis in pancreatic cancer cells via inhibition of Bcl-xL but not Bcl-2
    Morimoto, Yoshihito
    Takada, Kimihiko
    Takeuchi, Osamu
    Watanabe, Kazuhiro
    Hirohara, Masayoshi
    Hamamoto, Tomoyuki
    Masuda, Yutaka
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2020, 472 (1-2) : 187 - 198